Prabhudas Lilladher has come out with its third quarter (October-December’ 20) earnings estimates for the Pharma sector. The brokerage house expects Cadila Healthcare to report net profit at Rs. 373.9 crore up 37.6% year-on-year (up 8.7% quarter-on-quarter).
Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 3,638.1 crore, according to Prabhudas Lilladher.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 21.2 percent Y-o-Y (down 2.7 percent Q-o-Q) to Rs. 840 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.